CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.83
-0.02 (-0.25%)
Sep 28, 2026, 1:00 PM EDT - Market open
CorMedix Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Buy" and an average price target of $15.33. The average 1-year stock price forecast is 95.79% higher than the current stock price, while the lowest is $13 (+66.03%) and the highest is $19 (+142.66%).
Price Target: $15.33 (+95.79%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CorMedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Initiates $15 | Buy | Initiates | $15 | +91.57% | Sep 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +78.80% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +66.03% | Aug 14, 2026 |
| Needham | Needham | Buy Maintains $15 | Buy | Maintains | $15 | +91.57% | Aug 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $14 → $15 | Buy | Reiterates | $14 → $15 | +91.57% | May 15, 2026 |
Financial Forecast
Revenue This Year
337.06M
from 311.71M
Increased by 8.13%
Revenue Next Year
289.27M
from 337.06M
Decreased by -14.18%
EPS This Year
0.97
from 2.15
Decreased by -54.80%
EPS Next Year
0.35
from 0.97
Decreased by -63.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.